| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. | Nat Immunol | 2011 | 2.99 |
| 2 | Hepatic transcriptional networks induced by exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. | Chem Res Toxicol | 2007 | 0.93 |
| 3 | Identification of the Ah-receptor structural determinants for ligand preferences. | Toxicol Sci | 2012 | 0.89 |
| 4 | SU5416, a VEGF receptor inhibitor and ligand of the AHR, represents a new alternative for immunomodulation. | PLoS One | 2012 | 0.89 |
| 5 | A possible mechanism for atherosclerosis induced by polycyclic aromatic hydrocarbons. | Biochem Biophys Res Commun | 2005 | 0.78 |
| 6 | CYP1A1-mediated mechanism for atherosclerosis induced by polycyclic aromatic hydrocarbons. | Biochem Biophys Res Commun | 2005 | 0.77 |
| 7 | The Aryl Hydrocarbon Receptor is a Repressor of Inflammation-associated Colorectal Tumorigenesis in Mouse. | Ann Surg | 2016 | 0.76 |